Adrenal Incidentalomas: A Disease of Modern Technology Offering Opportunities for Improved Patient Care

Adriana G. Ioachimescu, Erick M. Remer, Amir Hamrahian

Research output: Contribution to journalReview article

Abstract

Adrenal incidentalomas (AIs) are found in approximately 4% of patients undergoing abdominal imaging, with peak prevalence in the sixth and seventh decades of life. Detection of AI warrants clinical, biochemical, and radiological evaluation to establish its secretory status and risk of malignancy. Careful review of the lipid content, size, and imaging phenotype of an adrenal mass is needed to evaluate the risk for malignancy. Identification of an AI may be an opportunity to identify an underlying secretory tumor that may have been otherwise unrecognized. A practical approach to investigation and follow-up of AIs is presented in this article.

Original languageEnglish (US)
Pages (from-to)335-354
Number of pages20
JournalEndocrinology and Metabolism Clinics of North America
Volume44
Issue number2
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Fingerprint

Patient Care
Technology
Neoplasms
Lipids
Adrenal incidentaloma

Keywords

  • Adrenal incidentaloma
  • Noncontrast CT attenuation
  • Percentage washout
  • Pheochromocytoma
  • Tumor size

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Medicine(all)

Cite this

Adrenal Incidentalomas : A Disease of Modern Technology Offering Opportunities for Improved Patient Care. / Ioachimescu, Adriana G.; Remer, Erick M.; Hamrahian, Amir.

In: Endocrinology and Metabolism Clinics of North America, Vol. 44, No. 2, 01.01.2015, p. 335-354.

Research output: Contribution to journalReview article

@article{0211d7dde43a4d5b85e3029582003b7d,
title = "Adrenal Incidentalomas: A Disease of Modern Technology Offering Opportunities for Improved Patient Care",
abstract = "Adrenal incidentalomas (AIs) are found in approximately 4{\%} of patients undergoing abdominal imaging, with peak prevalence in the sixth and seventh decades of life. Detection of AI warrants clinical, biochemical, and radiological evaluation to establish its secretory status and risk of malignancy. Careful review of the lipid content, size, and imaging phenotype of an adrenal mass is needed to evaluate the risk for malignancy. Identification of an AI may be an opportunity to identify an underlying secretory tumor that may have been otherwise unrecognized. A practical approach to investigation and follow-up of AIs is presented in this article.",
keywords = "Adrenal incidentaloma, Noncontrast CT attenuation, Percentage washout, Pheochromocytoma, Tumor size",
author = "Ioachimescu, {Adriana G.} and Remer, {Erick M.} and Amir Hamrahian",
year = "2015",
month = "1",
day = "1",
doi = "10.1016/j.ecl.2015.02.005",
language = "English (US)",
volume = "44",
pages = "335--354",
journal = "Endocrinology and Metabolism Clinics of North America",
issn = "0889-8529",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Adrenal Incidentalomas

T2 - A Disease of Modern Technology Offering Opportunities for Improved Patient Care

AU - Ioachimescu, Adriana G.

AU - Remer, Erick M.

AU - Hamrahian, Amir

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Adrenal incidentalomas (AIs) are found in approximately 4% of patients undergoing abdominal imaging, with peak prevalence in the sixth and seventh decades of life. Detection of AI warrants clinical, biochemical, and radiological evaluation to establish its secretory status and risk of malignancy. Careful review of the lipid content, size, and imaging phenotype of an adrenal mass is needed to evaluate the risk for malignancy. Identification of an AI may be an opportunity to identify an underlying secretory tumor that may have been otherwise unrecognized. A practical approach to investigation and follow-up of AIs is presented in this article.

AB - Adrenal incidentalomas (AIs) are found in approximately 4% of patients undergoing abdominal imaging, with peak prevalence in the sixth and seventh decades of life. Detection of AI warrants clinical, biochemical, and radiological evaluation to establish its secretory status and risk of malignancy. Careful review of the lipid content, size, and imaging phenotype of an adrenal mass is needed to evaluate the risk for malignancy. Identification of an AI may be an opportunity to identify an underlying secretory tumor that may have been otherwise unrecognized. A practical approach to investigation and follow-up of AIs is presented in this article.

KW - Adrenal incidentaloma

KW - Noncontrast CT attenuation

KW - Percentage washout

KW - Pheochromocytoma

KW - Tumor size

UR - http://www.scopus.com/inward/record.url?scp=84930325094&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930325094&partnerID=8YFLogxK

U2 - 10.1016/j.ecl.2015.02.005

DO - 10.1016/j.ecl.2015.02.005

M3 - Review article

C2 - 26038204

AN - SCOPUS:84930325094

VL - 44

SP - 335

EP - 354

JO - Endocrinology and Metabolism Clinics of North America

JF - Endocrinology and Metabolism Clinics of North America

SN - 0889-8529

IS - 2

ER -